AbL Diagnostics SA (ABLD) — Cash Flow Reinvestment Rate
AbL Diagnostics SA (ABLD) has a Cash Flow Reinvestment Rate of 0.84x as of June 2025, reinvesting €400.39K (capex €400.39K ) from operating cash flow of €479.46K. Check ABLD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AbL Diagnostics SA Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for AbL Diagnostics SA across 5 annual periods. Explore ABLD debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for AbL Diagnostics SA (2017–2025)
Year-by-year capital reinvestment analysis for AbL Diagnostics SA. For live market cap and broader valuation context, see market value of AbL Diagnostics SA.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | €792.67K | €1.51 Million | €792.67K | ▼ -48.1% |
| 2023 | 1.01x | €938.50K | €926.43K | €938.50K | — |
| 2020 | 0.00x | €0.00 | €29.51K | €0.00 | ▼ -100.0% |
| 2018 | 7.95x | €644.40K | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €305.02K | €675.20K | €305.02K | — |